R. Hider

发表

The Existence of Conformationally Labile (Preformed) Drug Binding Sites in Human Serum Albumin as Evidenced by Optical Rotation Measurements

A. Rosén, F. Walji, R. Hider, 1993, The Journal of pharmacy and pharmacology.

Potentiation of iron accumulation in cardiac myocytes during the treatment of iron overload in gerbils with the hydroxypyridinone iron chelator CP94

R. E. Edwards, B. Dorman, A. Smith, 1994, Biometals.

Iron mobilization from myocardial cells by 3-hydroxypyridin-4-one chelators: studies in rat heart cells in culture.

P. Dobbin, C. Hershko, A. Pinson, 1991, Blood.

Chelation and mobilization of cellular iron by different classes of chelators.

P. Milgram, J. Libman, A. Shanzer, 1997, Molecular pharmacology.

Effect of orally active hydroxypyridinone iron chelators on human lymphocyte function

P. Tongtawe, K. Pattanapanyasat, R. Hider, 1992, British journal of haematology.

Non‐transferrin‐bound iron induced by myeloablative chemotherapy

S. Srichairatanakool, R. Hider, S. Bradley, 1997, British journal of haematology.

Dissociation of a ferric maltol complex and its subsequent metabolism during absorption across the small intestine of the rat

M. Barrand, P. Dobbin, R. Hider, 1991, British journal of pharmacology.

Characteristics of iron(III) uptake by isolated fragments of rat small intestine in the presence of the hydroxypyrones, maltol and ethyl maltol.

M. Barrand, B. Callingham, R. Hider, 1988, Biochemical pharmacology.

Effects of the pyrones, maltol and ethyl maltol, on iron absorption from the rat small intestine

M. Barrand, R. Hider, B. Callingham, 1987, The Journal of pharmacy and pharmacology.

Recovering Ga(III) from coordination complexes using pyridine 2,6-dicarboxylic acid chelation ion chromatography.

X. Kong, P. Friden, R. Hider, 2010, Biomedical chromatography : BMC.

Effect of iron chelation on anti-pseudomonal activity of doxycycline

V. Abbate, A. Cilibrizzi, K. Bruce, 2021, International journal of antimicrobial agents.

Plants of Indian origin in drug discovery

P. Mukherjee, V. Kumar, S. Rai, 2007, Expert opinion on drug discovery.

Release of iron from ferritin molecules and their iron-cores by 3-hydroxypyridinone chelators in vitro.

P. Harrison, K. Lilley, P. Taylor, 1989, Journal of Inorganic Biochemistry.

New Orally Effective Iron Chelators

R. Grady, C. Hershko, A. Pinson, 1990, Annals of the New York Academy of Sciences.

Synthesis and physico-chemical properties of a series of bidentate

L. Saghaie, R. Hider, 2009 .

Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria.

H. Webster, D. Kyle, R. Udomsangpetch, 1997, Cytometry.

The Development of Hydroxypyridin‐4‐ones as Orally Active Iron Chelators

E. Huehns, S. Singh, R. Hider, 1990, Annals of the New York Academy of Sciences.

Iron mobilization from hepatocyte monolayer cultures by chelators: the importance of membrane permeability and the iron-binding constant.

E. Huehns, J. Porter, V. Saez, 1988, Blood.

In vivo evaluation of hydroxypyridone iron chelators in a mouse model.

E. Huehns, J. Porter, R. Hider, 1987, Acta haematologica.

Characterization of two isomeric β‐D‐glucosiduronic acids derived from 1,2‐diethyl‐3‐hydroxypyridin‐4‐one (CP94) in rat liver homogenate incubates

S. Piyamongkol, R. Hider, D. Liu, 2002, The Journal of pharmacy and pharmacology.

The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators.

P. Dobbin, C. Hershko, R. Hider, 1991, Blood.

Effects of hydroxypyridinone iron chelators in combination with antimalarial drugs on the in vitro growth of Plasmodium falciparum.

D. Kyle, K. Pattanapanyasat, D. Heppner, 2001, The Southeast Asian journal of tropical medicine and public health.

The antimalarial effect of iron chelators: studies in animal models and in humans with mild falciparum malaria.

D. Spira, T. Peto, G. Brittenham, 1992, Journal of inorganic biochemistry.

Studies in vitro on Free Amino Acid Pools and Protein Synthesis in Rat Jejunum

E. Fern, D. London, R. Hider, 1971, European journal of clinical investigation.

Microcomputer application of non-linear regression analysis to metal-ligand equilibria.

P. Taylor, I. Morrison, R. Hider, 1988, Talanta.

In‐vivo metabolism of 1‐(3′‐hydroxypropyl)‐2‐methyl‐3‐hydroxypyridin‐4‐one (CP41) and 1‐(2′‐hydroxyethyl)‐2‐ethyl‐3‐hydroxypyridin‐4‐one (CP102) by rat

R. Hider, D. Liu, S. Lu, 1998 .

ABSORPTION OF LOW AND THERAPEUTIC DOSES OF FERRIC MALTOL, A NOVEL FERRIC IRON COMPOUND, IN IRON DEFICIENT SUBJECTS USING A SINGLE DOSE IRON ABSORPTION TEST

R. Hider, D. Blake, A. Newland, 1991, Journal of clinical pharmacy and therapeutics.

Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores.

R. Grady, S. Zevin, C. Hershko, 1992, Blood.

Oral ferrous sulphate leads to a marked increase in pro‐oxidant nontransferrin‐bound iron

J. Powell, R. Hider, D. Liu, 2004, European journal of clinical investigation.

The interaction of orally administered iron with levodopa and methyldopa therapy

R. Hider, R. Greene, A. Hall, 1990, The Journal of pharmacy and pharmacology.

A proposal for the structure of apamin

U. Ragnarsson, R. Hider, 1980, FEBS letters.

Relative oral efficacy and acute toxicity of hydroxypyridin-4-one iron chelators in mice.

R. Hider, E. Huehns, J. Porter, 1990, Blood.

Incorporation of alphaxalone into different types of liposomes

R. Hider, T. Dean, 1993, The Journal of pharmacy and pharmacology.

Investigation of the anti-inflammatory properties of hydroxypyridinones.

R. Hider, C. Morris, D. Blake, 1989, Annals of the rheumatic diseases.